Should COVID 19 Immunization Products be Liability Free Indefinitely?
Updated: Oct 17, 2022
On October 19th and 20th, 2022 ACIP will be meeting to discuss adding the current covid vaccines to the CDC recommendation lists for both children and pregnant women. It is imperative that the advisory committee consider the current health risks and urgent concerns regarding these medical products. The meeting can be live streamed here.
Under the emergency use authorization the covid vaccines are exempt from liability. Since 1986 every vaccine added to the childhood schedule has a blanket liability shield for the manufacturers. If these products are added to the recommendation list, and the emergency use authorization ends, these products will have complete immunity liability indefinitely. This means the manufacturer, distributor, and medical professional administering the shot will not have to answer for any resulting injuries or death. The only resource in this scenario would be filing a claim for compensation with the federal government under the VAERS system and with vaccine injury compensation program. A system designed in cooperation with the pharmaceutical companies that offers limited compensation and often denies any serious claims because of their ever-changing allowances on the compensation tables.
Although CDC just issues recommendations, based on ACIP guidance, many states base their school mandates on these directives. Pharmaceutical companies now have the most powerful lobbying in history. They have worked strategically in coordination with local, state, and federal public health agencies to apply and enforce mandates for their liability free products. Although many states have exemptions information about them is not included in standard informed consent practices.
Your voice matters. Contact the ACIP Committee members today. Call, email, tweet, Facebook, and LinkedIn are all methods you can use to express your concerns. Please use the hashtags #ACIP #ACIPVOTENO #Covidliabilityshield #covidvaccines #stopthemandates
“The ACIP includes 15 voting members responsible for making vaccine recommendations. The Secretary of the U.S. Department of Health and Human Services (DHHS) selects these members following an application and nomination process. Fourteen of the members have expertise in vaccinology, immunology, pediatrics, internal medicine, nursing, family medicine, virology, public health, infectious diseases, and/or preventive medicine; one member is a consumer representative who provides perspectives on the social and community aspects of vaccination.
In addition to the 15 voting members, ACIP includes 8 ex officio members who represent other federal agencies with responsibility for immunization programs in the United States, and 30 non-voting representatives of liaison organizations that bring related immunization expertise.
Members and representatives serve on the Committee voluntarily.”
LEE, Grace M., MD, MPH Associate Chief Medical Officer for Practice Innovation Lucile Packard Children’s Hospital Professor of Pediatrics, Stanford University School of Medicine Stanford, CA Term: 8/4/2021 – 6/30/2023
WHARTON, Melinda, MD, MPH National Center for Immunization and Respiratory Diseases Centers for Disease Control and Prevention Atlanta, GA
BAHTA, Lynn, RN, MPH, CPH Immunization Program Clinical Consultant Infectious Disease, Epidemiology, Prevention & Control Division Minnesota Department of Health Saint Paul, Minnesota Term: 7/1/2019 – 6/30/2023
BELL, Beth P., MD, MPH Clinical Professor Department of Global Health, School of Public Health University of Washington Seattle, WA Term: 7/1/2019 – 6/30/2023
BROOKS, Oliver, MD, FAAP Chief Medical Officer Watts HealthCare Corporation Los Angeles, CA Past President, National Medical Association Term: 7/26/2021 – 6/30/2025
CHEN, Wilbur H., MD, MS, FACP, FIDSA Professor of Medicine Center for Vaccine Development and Global Health University of Maryland School of Medicine Baltimore, MD Term: 12/23/2020 – 6/30/2024
CINEAS, Sybil, MD, FAAP, FACP Associate Professor of Medicine, Pediatrics, and Medical Science (Clinical) The Warren Alpert Medical School of Brown University Associate Program Director Brown Combined Residency in Internal Medicine and Pediatrics Providence, RI Term: 7/28/2021 – 6/30/2025
DALEY, Matthew F., MD Senior Investigator Institute for Health Research Kaiser Permanente Colorado Aurora, CO Term: 1/4/2021 – 6/30/2024
KOTTON, Camille Nelson, MD, FIDSA, FAST Clinical Director, Transplant and Immunocompromised Host Infectious Diseases Infectious Diseases Division, Massachusetts General Hospital Associate Professor of Medicine, Harvard Medical School Boston, MA Term: 12/23/2020 – 6/30/2024
LOEHR, Jamie, MD, FAAFP Owner, Cayuga Family Medicine Ithaca, New York Term: 7/26/2021 – 6/30/2025
LONG, Sarah S., MD Professor of Pediatrics Drexel University College of Medicine Section of Infectious Diseases St. Christopher’s Hospital for Children Philadelphia, Pennsylvania Term: 12/24/2020 – 6/30/2024
MCNALLY, Veronica V., JD President and CEO Franny Strong Foundation West Bloomfield, Michigan Term: 10/31/2018 – 6/30/2023
POEHLING, Katherine A., MD, MPH Professor of Pediatrics and Epidemiology and Prevention Director, Pediatric Population Health Department of Pediatrics Wake Forest School of Medicine Winston-Salem, NC Term: 7/1/2019 – 6/30/2023
SÁNCHEZ, Pablo J., M.D. Professor of Pediatrics The Ohio State University – Nationwide Children’s Hospital Divisions of Neonatal-Perinatal Medicine and Pediatric Infectious Diseases Director, Clinical & Translational Research (Neonatology) Center for Perinatal Research The Research Institute at Nationwide Children’s Hospital Columbus, Ohio Term: 7/1/2019 – 6/30/2023
SHAH, Nirav D., MD, JD Director Maine Center for Disease Control and Prevention Augusta, ME Term: 9/26/2022 – 6/30/2026
TALBOT, Helen Keipp, MD Associate Professor of Medicine Vanderbilt University Nashville, TN Term: 10/29/2018 – 6/30/2023
Dr. Sarah Long 215-427-5201
Dr. Grace Lee 650-497-0618
Lynn Bahta (an RN) 651-201-5505
Dr. Beth Bell 404-432-3059
Dr. Oliver Brooks 323-564-4331
Dr. Wilbur Chen 410-706-5328
Dr. Sybil Cineas 401-444-4741
Dr. Helen Keipp Talbot 615-322-2035
Dr. Matthew Daley 303-393-6604
Dr. Camille Nelson Kotton 617-726-3812
Dr. Jamie Loehr 607-697-0360
Veronica V. McNally (an attorney) 517-432-6969
Dr. Katherine A. Poehling 336-716-9661 extension: 62540
Dr. Pablo J. Sánchez 614-722-4559
Dr. Nirav D. Shah 312-952-6092
Additionally, public comments can be made on the meeting docket when it is posted here.
Resources for concerns regard covid immunizations;